ResearcherAmsterdam University Medical CentersNo recent work listed
Cansu Tekin
Matched on ORCID iD 0000-0003-3961-5603; OpenAlex author ID A5043392065. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2018: 1 paper · 2019: none · 2020: 4 papers
Papers 5
- Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activation. Co-author DOI 10.1007/s13402-020-00549-x↗
- Early macrophage infiltrates impair pancreatic cancer cell growth by TNF-α secretion. Co-author DOI 10.1186/s12885-020-07697-1↗
- High-grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF-1. Co-author DOI 10.15252/embr.201948780↗
- Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression? Co-author DOI 10.3390/biology9040080↗
- PAR1 signaling on tumor cells limits tumor growth by maintaining a mesenchymal phenotype in pancreatic cancer. Co-author DOI 10.18632/oncotarget.25880↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Maarten F. Bijlsma · 5 shared papers, 2018–2020 · strength 0.61
- Paper Early macrophage infiltrates impair pancreatic cancer cell growth by TNF-α secretion. DOI 10.1186/s12885-020-07697-1↗
- Paper Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression? DOI 10.3390/biology9040080↗
- Paper Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activation. DOI 10.1007/s13402-020-00549-x↗
- C. Arnold Spek · 4 shared papers, 2018–2020 · strength 0.52
- Paper Early macrophage infiltrates impair pancreatic cancer cell growth by TNF-α secretion. DOI 10.1186/s12885-020-07697-1↗
- Paper Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression? DOI 10.3390/biology9040080↗
- Paper Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activation. DOI 10.1007/s13402-020-00549-x↗
- Frederike Dijk · 2 shared papers, 2020 · strength 0.20
- Etienne J. Slapak · 1 shared paper, 2020 · strength 0.15
- JanWillem Duitman · 1 shared paper, 2020 · strength 0.15
- Kun Shi · 1 shared paper, 2018 · strength 0.10
- Remy Klaassen · 1 shared paper, 2020 · strength 0.09
- Johanna W. Wilmink · 1 shared paper, 2020 · strength 0.09
- Geertjan van Tienhoven · 1 shared paper, 2020 · strength 0.09
- Madelaine G. van Mackelenbergh · 1 shared paper, 2020 · strength 0.09
- Hanneke W.M. van Laarhoven · 1 shared paper, 2020 · strength 0.09
- Joanne Verheij · 1 shared paper, 2020 · strength 0.09
- Anne Steins · 1 shared paper, 2020 · strength 0.09
- Marc G. Besselink · 1 shared paper, 2020 · strength 0.09
- Hemant Mahendrakumar Kocher · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.